Physician profile
John B Williams
NPI 1982605598
$3,435.07
in general payments reported to CMS, 2019-2025
19 companies · $14.86 in 2025
The $14.86 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $715 · 2020: $1,258 · 2021: $315 · 2022: $416 · 2023: $374 · 2024: $343 · 2025: $14.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $731.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $1,550.00 | 2019-2020 | |
| Dexcom, INC. | $442.33 | 2019-2024 | Dexcom G6 Transmitter |
| Abbott Laboratories | $438.39 | 2021-2024 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $187.50 | 2022-2023 | |
| Asensus Surgical, INC. | $160.45 | 2019 | |
| Amgen INC. | $139.29 | 2021-2025 | Tepezza |
| Esperion Therapeutics, INC. | $124.36 | 2021 | |
| Horizon Therapeutics Plc | $88.99 | 2020 | |
| Novo Nordisk INC | $50.11 | 2019-2024 | Ozempic, Rybelsus |
| Nevro Corp. | $45.93 | 2022-2023 | Senza |
| Abbvie INC. | $42.04 | 2022-2023 | Synthroid |
| Gilead Sciences, INC. | $34.22 | 2019 | |
| Pfizer INC. | $29.44 | 2021-2022 | |
| Cequr Corporation | $23.52 | 2024 | Cequr Simplicity |
| Medtronic Minimed, INC. | $18.64 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $17.65 | 2019 | |
| Amneal Pharmaceuticals LLC | $16.24 | 2024 | Unithroid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.63 | 2019 | |
| Sanofi Pasteur INC. | $12.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.